RBC Capital Downgrades Sagent Pharmaceuticals (SGNT) to Sector Perform

RBC Capital downgraded Sagent Pharmaceuticals (NASDAQ: SGNT) from Outperform to Sector Perform with a price target of $16.00 (from $24.00).

For an analyst ratings summary and ratings history on Sagent Pharmaceuticals click here. For more ratings news on Sagent Pharmaceuticals click here.

Shares of Sagent Pharmaceuticals closed at $13.25 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
• CJS Securities Downgrades Varex Imaging (VREX) to Market Perform
• ATB Capital Markets Downgrades The Westaim Corp. (WED:CN) (WEDXF) to Speculative Buy (2)